4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-206344
President & CEO sold 5,467 shares at $18.92 ($103,447)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Warmuth Markus · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-01 | Sale : show line 1 in the form 10b5-1 | −5,467 | $18.92 | $103,447 | 600,004 | D |
| Open-market sales · 5,467 sh · avg $18.92 · $103,447 | ||||||
Loading xslF345X06/ownership.xml…